Another RW study conducted in Italy, the DARWIN-T2D, assessed the albumin excretion rate (AER) as a surrogate of kidney outcome in T2DM patients treated with dapagliflozin vs. active comparators (i.e., GLPR-1a, DPP-4i, or glicazide) [48]. Here, ALB is linked to type 2 diabetes mellitus.